Bacterial Phenotypic Diversity

$285,834U54FY2009AINIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Paper 36744930 Paper 35665714 Paper 35665712 Paper 34398663 Paper 31088976 Paper 30482849 Paper 30395379 Paper 29038248 Paper 29020088 Paper 27682622 Paper 27573815 Paper 27345162 Paper 27183270 Paper 27128945 Paper 27060837 Paper 27019597 Paper 27003047 Paper 26956590 Paper 26572063 Paper 26320999 Paper 26269231 Paper 26060330 Paper 25845845 Paper 25713353 Paper 25643951 Paper 25422302 Paper 25378593 Paper 25373147 Paper 25350459 Paper 25232720 Paper 25215494 Paper 25182491 Paper 24850346 Paper 24724055 Paper 24618686 Paper 24616423 Paper 24581694 Paper 24532601 Paper 24499818 Paper 24464461 Paper 24452686 Paper 24446487 Paper 24384601 Paper 24367258 Paper 24347546 Paper 24303060 Paper 24298015 Paper 24213920 Paper 24194535 Paper 24173717 Paper 24054327 Paper 24031018 Paper 23935492 Paper 23924613 Paper 23890008 Paper 23852598 Paper 23798540 Paper 23707339 Paper 23686263 Paper 23657959 Paper 23552891 Paper 23505561 Paper 23478521 Paper 23447684 Paper 23438649 Paper 23429539 Paper 23348507 Paper 23249812 Paper 23245324 Paper 23245318 Paper 23238751 Paper 23209222 Paper 23151486 Paper 23150540 Paper 23150539 Paper 23136994 Paper 23071439 Paper 23062469 Paper 23045604 Paper 22988113 Paper 22840407 Paper 22837397 Paper 22798355 Paper 22763647 Paper 22746332 Paper 22742654 Paper 22740689 Paper 22719259 Paper 22663564 Paper 22660718 Paper 22624013 Paper 22623373 Paper 22615773 Paper 22607806 Paper 22586119 Paper 22563295 Paper 22549780 Paper 22476889 Paper 22434848 Paper 22215738

Abstract

The primary goal of the research is to identify the FT and BP genes responsible for several intrinsic antibiotic resistance, virulence and stress tolerance traits. The results should provide mechanistic insights into the physiological basis of each and may identify potential antibacterial drug targets. An additional set of experiments will help define BP species diversity in these and other phenotypes, and may identify diagnostic tests to differentiate natural isolates. As part of the project, a new-generation sequencing-based technology for assessing the makeup of transposon mutant pools of will be developed.

View original record on NIH RePORTER →